The evaluation of a successful home hemodialysis program: Establishing a prospective framework for quality

Clinical Nephrology

Volumn 71, Issue 5, 2009, Pages 467-474

  Komenda, Paul ^a   Chan, C ^b   Pauly, R P ^c   Levin, A ^d   Copland, M ^d   Pierratos, A ^e   Sood, M M ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Benchmarks; Evaluation; Home hemodialysis; Quality

Indexed keywords

COST BENEFIT ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HOME DIALYSIS; HUMAN; OUTCOME ASSESSMENT; PATIENT CARE; QUALITY OF LIFE; REVIEW; TREND STUDY; CANADA; CHRONIC KIDNEY FAILURE; ECONOMICS; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PROSPECTIVE STUDY; QUALITY CONTROL; STANDARD;

BENCHMARKING; CANADA; HEMODIALYSIS, HOME; HUMANS; KIDNEY FAILURE, CHRONIC; PROSPECTIVE STUDIES; QUALITY ASSURANCE, HEALTH CARE;

EID: 67649406319     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Agar JW. Nocturnal haemodialysis in Australia and New Zealand. Nephrology (Carlton). 2005; 10: 222-230.
2. Agar JW, Knight RJ, Simmonds RE et al. Nocturnal haemodialysis: an Australian cost comparison with conventional satellite haemodialysis. Nephrology (Carlton). 2005; 10: 557-570.
3. Al-Hejaili F, Kortas C, Leitch R et al. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol. 2003; 14: 2322-2328.
4. Ayus JC, Mizani MR, Achinger, SG, Thadhani R, Go AS, Lee S. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol. 2005; 16: 2778-2788.
5. Blagg CR. What went wrong with home hemodialysis in the United States and what can be done now? Hemodial Int. 2000; 4: 55-58.
6. Bolgg A., Hyde C. Enhancing lifestyle through home haemodialysis. Edtna Erca J. 2006; 32: 179-182.
7. Chan CT, Floras JS, Miller JA, Pierratos A. Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant. 2002a; 17: 1518-1521.
8. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int. 2002b; 61: 2235-2239.
9. Chan CT, Harvey PJ, Picton P, Pierratos A, Miller JA, Floras JS. Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis. Hypertension. 2003; 42: 925-931.
10. Chan CT, Notarius CF, Merlooco AC, Floras JS. Improvement in exercise duration and capacity after conversion to nocturnal home haemodialysis. Nephrol Dial Transplant. 2007; 22: 3285-3291.
11. Collins AJ, Kasiske B et al. Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis. 2007; 49 (Suppl 1): A6-7, S1-296.
12. Collins AJ, Foley R et al. Excerpts from the United States Renal Data System 2007 Annual Data Report. Am J Kidney Dis. 2008; 51 (Suppl 1): S1-320.
13. Culleton B, Walsh M, Klarenbach SW, Mortis, G. Scott-Douglas N, Quinn R, Tonelli M, Donnelly S, Friedrich MG, Kumar A, Mahallati H, Hemmelgarn B, Manns B. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life. JAMA. 2007; 298: 9.
14. Devereaux PJ, Schunemann HJ et al. Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: a systematic review and meta-analysis. JAMA. 2002; 288: 2449-2457.
15. Finkelstein FO, Finkelstein SH, Wuerth D, Shirani S, Troidle L. Effects of home hemodialysis on health-related quality of life measures. Semin Dial. 2007; 20: 265-268.
16. Foley RN, Fan Q et al. Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: a retrospective analysis. BMC Nephrol. 2008; 9: 6.
17. Gilpatrick E. Quality Improvement Projects in Health Care. Thousand Oaks, CA, USA: Sage Publications; 1998.
18. Hanly PJ, Gabor JY, Chan C, Pierratos A. Daytime sleepiness in patients with CRF: impact of nocturnal hemodialysis. Am J Kidney Dis. 2003; 41: 403-410.
19. Heidenheim AP, Muirhead N, Moist L, Lindsay RM. Patient quality of life on quotidian hemodialysis. Am J Kidney Dis. 2003; 42 (Suppl): 36-41.
20. Helgerson SD, McClellan WM, Frederick PR, Beaver SK, Frankenfield DL, McMullan M. Improvement in adequacy of delivered dialysis for adult in-center hemodialysis patients in the United States, 1993 to 1995. Am J Kidney Dis. 1997; 29: 851-861.
21. Kjellstrand CM, Buoncristiani U et al. Short daily haemodialysis: survival in 415 patients treated for 1006 patient-years. Nephrol Dial Transplant. 2008; 23: 3283-3289.
22. Komenda P, Levin A, Manns B. The economics of home nocturnal hemodialysis: How should we cost the benefits? Clin Nephrol. 2007; 68: 8.
23. Komenda P, Copland M, Er L, Djurdjev O, Levin A. Outcomes of a provincial home haemodialysis programme - a two-year experience: establishing benchmarks for programme evaluation. Nephrol Dial Transplant. 2008; 23: 2647-2652.
24. Kooistra MP, Vos J, Koomans HA, Vos PF. Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant. 1998; 13: 2853-2860.
25. Kroeker A, Clark WF et al. An operating cost comparison between conventional and home quotidian hemodialysis. Am J Kidney Dis. 2003; 42 (Suppl): 49-55.
26. Krumholz HM, Lee TH. Redefining quality - implications of recent clinical trials. N Engl J Med. 2008; 358: 2537-2539.
27. Laupacis A, Keown P, Pus N et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int. 1996; 50: 235-242.
28. Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, Donaldson C. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis. 2002; 40: 611-622.
29. Lockridge RS Jr. Daily dialysis and long-term outcomes - the Lynchburg Nephrology NHHD experience. Nephrol News Issues. 1999; 13: 16, 19, 23-26.
30. MacGregor MS, Agar JW, Blagg CR. Home haemodialysis - international trends and variation. Nephrol Dial Transplant. 2006; 21: 1934-1945.
31. McClellan W, Soucie JM. Facility mortality rates for new end-stage renal disease patients: implications for quality improvement. Am J Kidney Dis. 1994a; 24: 280-289.
32. McClellan W, Soucie JM. Mortality in end-stage renal disease is associated with facility-to-facility differences in adequacy of hemodialysis. J Am Soc Nephrol. 1994b; 9: 1940-1947.
33. McFarlane PA. Reducing hemodialysis costs: conventional and quotidian home hemodialysis in Canada. Semin Dial. 2004; 17: 118-124.
34. McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA. The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int. 2003; 64: 1004-1011.
35. McFarlane PA, Pierratos A, Bayoumi AM, Redelmeier DA. Estimating preference scores in conventional and home nocturnal hemodialysis patients. Clin J Am Soc Nephrol. 2007; 2: 477-483.
36. McPhatter L, Lockridger RS Jr., Albert J et al. Nightly home hemodialysis: improvement in nutrition and quality of life. Adv Ren Replace Ther. 1999; 6: 358-365.
37. Mendelssohn DC, Pisoni RL, Arrington CJ et al. Apractice-related risk score (PRS): a DOPPS-derived aggregate quality index for haemodialysis facilities. Nephrol Dial Transplant. 2008; 23: 3227-3233.
38. O'Sullivan DA, McCarthy JT, Kumar R, Williams AW. Improved biochemical variables, nutrient intake, and hormonal factors in slow nocturnal hemodialysis: a pilot study. Mayo Clin Proc. 1998; 73: 1035-1045.
39. Pauly R, Copland M, Komenda P, Levin A, Pierratos A, Chan CT. Utility and limitations of a multicentre nocturnal home hemodialysis cohort. Clin J Am Soc Nephrol. 2008; 3: 1846-1851.
40. Petra E, Varughese P, Epifania L, Buneo L, Scarfone K. Use of quality index tracking to drive improvement in clinical outcomes. Nephrol News Issues. 2006; 20: 67-68, 70-71, 83.
41. Shaldon S, Oakley J J. Experience with regular haemodialysis in the home. Br J Urol. 1966; 38: 616-620.
42. Spanner E, Suri R, Heidenheim AP, Linday RM. The impact of quotidian hemodialysis on nutrition. Am J Kidney Dis. 2003; 42 (Suppl): 30-35.
43. Suri RS, Nesrallah GE, Mainra R, Garg AX, Lindsay RM, Greene T, Daugirdas JT. Daily hemodialysis: a systematic review. Clin J Am Soc Nephrol. 2006; 1: 33-42.
44. Suri RS, Garg AX, Chertow GM et al. Frequent Hemodialysis Network (FHN) randomized trials: study design. Kidney Int. 2007; 71: 349-359.
45. Ting GO, Kjellstrand C, Freitas T, Carrie BJ, Zarghamee S. Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis. 2003; 42: 1020-1035.
46. Uldall R, Ouwendyk M, Francoeur R, Wallace L, Sit W, Vas S, Pierratos A. Slow nocturnal home hemodialysis at the Wellesley Hospital. Adv Ren Replace Ther. 1996; 3: 133-136.
47. Van Eps C, Jeffries JK, Anderson JA et al. Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis. Nephrology (Carlton). 2007; 12: 224-233.
48. Walsh M, Culleton B, Tonelli M, Manns B. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int. 2005; 67: 1500-1508.